Roche cuts drug pipeline in effort to revitalise business
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Roche has cut a fifth of its drug pipeline in six months, shedding prospective cancer and neurology treatments as the Swiss company …